Biological activity of LALF32-51–E7, a vaccine candidate for the treatment of anogenital lesions associated to HPV16

Authors: Alfonso, Alain B., Granadillo, Milaid, Batte, Aileen, Brown, Enma, Limonta, Miladys, Soler, Dayana, Torres, Dinorah, Prieto, Yayrí C., Varas, Laura, Torrens, Isis

Source: In Journal of Cellular Immunotherapy December 2018 4(2):71-74

Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate

Authors: Granadillo, Milaid, Batte, Aileen, Alfonso, Alain B., Blanco, Aracelys, Urquiza, Dioslaida, Varas, Laura, Soler, Dayana, Miyares, Maelys, Limonta, Miladys, Torrens, Isis

Source: Vaccine. 37(30):3957-3960

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100084046234.0x000001&indx=1&recIds=ETOCvdc_100084046234.0x000001

The LALF32-51 peptide as component of HPV therapeutic vaccine circumvents the alum-mediated inhibition of IL-12 and promotes a Th1 response

Authors: Granadillo, Milaid, Alfonso, Alain B., Vallespi, Maribel G., Batte, Aileen, Soria, Yordanka, Brown, Enma, Limonta, Miladys, Prieto, Yayrí C., Varas, Laura, Torrens, Isis

Source: In Journal of Cellular Immunotherapy March 2016 2(1):44-51

A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice

Authors: Granadillo, Milaid, Vallespi, Maribel G., Batte, Aileen, Mendoza, Osmany, Soria, Yordanka, Lugo, Victoria M., Torrens, Isis

Source: In Vaccine 29 January 2011 29(5):920-930

Immunotherapy with CTL peptide and VSSP eradicated established human papillomavirus (HPV) type 16 E7-expressing tumors

Authors: Torréns, Isis, Mendoza, Osmany, Batte, Aileen, Reyes, Osvaldo, Fernández, Luis E., Mesa, Circe, Guillén, Gerardo

Source: In Vaccine 2005 23(50):5768-5774

This result is not displayed to guests.
Login for full access.

LALF-E7 therapeutic vaccine induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the lungs.

Authors: Granadillo, Milaid, Batte, Aileen, Blanco, Aracelys, Alfonso, Alain, Suárez, José, Merino, Nelson, Carballo, Rosalina, González, Bárbara, Prieto, Yayrí, Varas, Laura, Soler, Dayana, Limonta, Miladys, Miyares, Maelys, Aldana, Lizet, Torrens, Isis

Source: Clinical & Experimental Metastasis; Apr2017, Vol. 34 Issue 3/4, p241-249, 9p

This result is not displayed to guests.
Login for full access.

Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.

Authors: Solares, Ana M., Baladron, Idania, Ramos, Thelvia, Valenzuela, Carmen, Borbon, Zaida, Fanjull, Sonia, Gonzalez, Leonardo, Castillo, Dagnelia, Esmir, Julio, Granadillo, Milaid, Batte, Aileen, Cintado, Alberto, Ale, Mayte, de Cossio, Maria E. Fernandez, Ferrer, Annia, Torrens, Isis, Lopez-Saura, Pedro, Fernandez de Cossio, Maria E

Source: ISRN Obstetrics & Gynecology; 2011, Special section p1-9, 9p

Subject Terms: PAPILLOMAVIRUS diseases, PEPTIDES, CERVICAL cancer research, VACCINE research, VACCINE safety

A novel strategy to improve antigen presentation for active immunotherapy in cancer. Fusion of the human papillomavirus type 16 E7 antigen to a cell penetrating peptide.

Alternate Title: Nueva estrategia para mejorar la presentación antigénica en la inmunoterapia activa del cáncer. Fusión del antígeno E7 del virus del papiloma humano tipo 16 a un péptido penetrador a células.

Authors: Granadillo, Milaid¹ milaid.granadillo@cigb.edu.cu, Torrens, Isis¹, Guerra, Maribel¹, Batte, Aileen¹, Soria, Yordanka², Mendoza, Osmani², Blanco, Aracelys², Musacchio, Alexis³, Lugo, Victoria M.⁴

Source: Biotecnologia Aplicada. 2012, Vol. 29 Issue 3, p194-197. 4p.

Subject Terms: *ANTIGEN presenting cells, *IMMUNOTHERAPY, *PAPILLOMAVIRUSES, *CHIMERIC proteins, *BACTERICIDAL action, *LIMULUS polyphemus, *CANCER treatment, *MAJOR histocompatibility complex

A vaccine candidate against the human papillomavirus: an alternative to treat cervico-uterine tumors.

Authors: del Carmen Torréns, Isis¹ isis.torrens@cigb.edu.cu, Mendoza, Osmany¹, Reyes, Osvaldo¹, Batte, Aileen¹, Granadillo, Milaid¹, Fernández, Luis E.², Guillén, Gerardo¹

Source: Biotecnologia Aplicada. abr-jun2008, Vol. 25 Issue 2, p180-182. 3p. 1 Chart, 2 Graphs.

Subject Terms: *PAPILLOMAVIRUSES, *CERVICAL cancer treatment, *VIRAL antigens, *CANCER vaccines, *IMMUNOTHERAPY, *SPONTANEOUS cancer regression, *RESEARCH methodology, *LABORATORY mice, *THERAPEUTICS

Candidato vacunal contra el virus de papiloma humano: alternativa para el tratamiento de tumores cervico-uterinos.

Authors: Del Carmen Torréns, Isis¹ isis.torrens@cigb.edu.cu, Mendoza, Osmany¹, Reyes, Osvaldo¹, Batte, Aileen¹, Granadillo, Milaid¹, Fernández, Luis E.², Guillén, Gerardo¹

Source: Biotecnologia Aplicada. abr-jun2008, Vol. 25 Issue 2, p177-179. 3p. 1 Chart, 2 Graphs.

Subject Terms: *PAPILLOMAVIRUSES, *CERVICAL cancer treatment, *VIRAL antigens, *IMMUNOTHERAPY, *SPONTANEOUS cancer regression, *LABORATORY mice, *THERAPEUTICS